
About Zenvision Pharma
Zenvision Pharma is a Healthcare company based in Mumbai (India) founded in 2015 by B V Sivakumar. It provides pharmaceutical formulation development and contract manufacturing services globally. It operates on a B2B model. Its chief executive, as recorded, is B V Sivakumar. Its Indian entity Msp Medicines Llp reported revenue of βΉ27.90 Cr. Zenvision Pharma offers products and services including Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer. Its focus areas include Pharmaceuticals, CDMO, Formulation Development and Manufacturing. Its competitors include Syngene, Piramal Group and Panacea Biotec; 1 of its 3 listed competitors has raised funding.
Company details
Zenvision Pharma is a comprehensive CDMO specializing in formulation and product development for highly regulated markets like the US and Europe, as well as semi-regulated ones. It operates with state-of-the-art RD and manufacturing facilities in Navi Mumbai, India, and has an office in Leicester, UK. The company focuses on services including contract manufacturing, analytical development, and technology transfer, emphasizing quality, innovation, and sustainable practices to support global pharmaceutical partners.
- Headquarters Mumbai, India
- Employees 98
- Founders B V Sivakumar
- SectorsHealthcare
- Website zenvisionpharma.com
- Social Facebook Instagram
- Legal Name Msp Medicines Llp
- Date of Incorporation 19 Jun, 2015
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹27.90 Cr
FY 2023
- Net Profit₹4.89 Cr
FY 2023 · 18% margin
- EBITDA₹10.38 Cr
FY 2023 · 37% margin
- Employee Count98
Associated legal entities of Zenvision Pharma
Zenvision Pharma operates through Msp Medicines Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Msp Medicines Llp CIN AAE-2082 | Active | 19 Jun 2015 | Mumbai, Maharashtra | ₹27.9 Cr | 98 | 2 | View details |
Products & Services of Zenvision Pharma
Zenvision Pharma offers a comprehensive portfolio of products and services, including Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer.
Develops pharmaceutical formulations for regulated and semi-regulated markets
Produces pharmaceutical products under contract for partners
Conducts analytical testing for product quality and compliance
Transfers technology for efficient product scaling and production
Board of directors of Msp Medicines Llp (Zenvision Pharma)
Msp Medicines Llp is the primary company behind Zenvision Pharma. The board of Msp Medicines Llp currently have 2 directors; the longest-serving is Sunil Haripant Pophale, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Haripant Pophale DIN 00064412 | Designated Partner | 19 Jun 2015 | 11 yrs 5 mo | Msp Medicines Llp |
| Paras Vinod Gandhi DIN 10140597 | Partner | 01 Sep 2020 | 6 yrs 2 mo | Msp Medicines Llp |
People of Zenvision Pharma
1 people are tracked at Zenvision Pharma (1 in leadership); the tracked headcount is 98.
| Name | Role | Group |
|---|---|---|
B V Sivakumar | Co-Founder, CEO | Leadership |
Complete people profiles for Zenvision Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Zenvision Pharma
Figures of Msp Medicines Llp, the primary company behind Zenvision Pharma, for FY 2023. Revenue was ₹27.90 Cr. Net profit was ₹4.89 Cr (18% margin). EBITDA was ₹10.38 Cr (37% margin). Revenue has grown at a compounded annual rate of +51% over three years and +83% over five years.
- ₹27.90 CrRevenue · FY 2023
- ₹4.89 CrNet profit · 18% margin
- ₹10.38 CrEBITDA · 37% margin
- 98Employees (provident fund records)
- +51%Revenue CAGR, 3 years
- +83%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Msp Medicines Llp are on its company page.
Detailed financial statements for Zenvision Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Zenvision Pharma
Zenvision Pharma has 3 listed competitors in our database, 1 of them funded. They include Syngene, Piramal Group and Panacea Biotec.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| syngeneintl.com | 1993 | Bengaluru, India | $85.89M | 5,618 | Provider of contract research and manufacturing services for both small molecules and biologics | |
| piramal.com | 1984 | Mumbai, India | 204 | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | ||
| panaceabiotec.com | 1984 | Ambala, India | 2,095 | Developer of biosimilars, vaccines and natural products |
Detailed competitors of Zenvision Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zenvision Pharma
Zenvision Pharma was founded in 2015.
Zenvision Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
B V Sivakumar is the CEO of Zenvision Pharma, as recorded in our data. They have also founded this company.
Zenvision Pharma has 98 employees.
The primary company behind Zenvision Pharma, Msp Medicines Llp, reported revenue of βΉ27.90 Cr for FY 2023.
Zenvision Pharma is a comprehensive CDMO specializing in formulation and product development for highly regulated markets like the US and Europe, as well as semi-regulated ones. It operates with state-of-the-art RD and manufacturing facilities in Navi Mumbai, India, and has an office in Leicester, UK. The company focuses on services including contract manufacturing, analytical development, and technology transfer, emphasizing quality, innovation, and sustainable practices to support global pharmaceutical partners.
Zenvision Pharma's top competitors include Syngene, Panacea Biotec and Piramal Group.
Zenvision Pharma offers Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer.
Zenvision Pharma operates through Msp Medicines Llp.
The legal entities of Zenvision Pharma currently have 2 directors, including Sunil Haripant Pophale, Paras Vinod Gandhi.